What We Know: A popular antidepressant sold across the country is being recalled after elevated levels of a potentially cancer-causing chemical were discovered.
What’s Next: The recall affects nearly 360,000 bottles of duloxetine delayed-release capsules, a generic version of Cymbalta.
According to the U.S. Food and Drug Administration, manufacturer Breckenridge Pharmaceutical issued the recall on June 4 after testing found high levels of nitrosamines.
Nitrosamines are chemical compounds that may increase cancer risk with long-term exposure.
The recalled medication includes both 30-milligram and 60-milligram capsules distributed nationwide.
Several lot numbers and expiration dates are affected.
Patients who take duloxetine are encouraged to check their prescription bottles and contact their doctor or pharmacist if they have questions.
Health experts stress that patients should not stop taking the medication without first speaking with a medical professional.
More information about the affected lot numbers is available through the FDA recall notice.
(Photo courtesy of Envato)